Fetch autonomous agents have been created to maximise asset utilisation and provide personalised predictions for Clustermarket’s users and providers.
Insert date September 2018, Cambridge, United Kingdom: Fetch.AI today announces that Clustermarket, an online sharing platform for scientific equipment and services, will deploy over 600 Fetch Autonomous Economic Agents. The agents will be deployed on Fetch.AI’s decentralised network but connected to Culstermarket’s online marketplace to improve how scientific equipment and services are booked and allocated across the UK.
Clustermarket is an online booking tool for basic and scarce scientific equipment and services that connects laboratories at institutions like Imperial College, UCL, King’s College and the University of Cambridge with scientists, companies and organisations that wish to use the machines or outsource experiments. The platform
Exciting life sciences startups from around the world are kicking off their acceleration in London this week. RebelBio, the world’s first life sciences accelerator and owned by SOSV, has taken on seven companies for Cohort VI and they are working on some extremely innovative and disruptive tech. Whether you are into sustainability in the food sector, artificial intelligence and machine learning, neurodegenerative disease or the microbiome (to name a few) there is something here that you’ll want to follow. These companies include science lovers from a range of backgrounds, including BScs, MBAs, PhDs, doctors, surgeons, CEOs and visionaries, who are being thrust into a full-on three month programme including investment, mentorship and business training with RebelBio.
As part of this month’s #genomejuly topic I was interested in the advances of the epigenome innovations in the biotech industry. I, therefore, recently spoke with Chronomics CEO, Dr. Tom Stubbs. Chronomics is a startup that brings personalised epigenetic testing directly to the everyday consumer. They offer a saliva test that will enable you to track epigenetic changes as a consequence of your diet, environment and lifestyle. Epigenetics is the study of alterations in the expression of genes without direct changes to the genetic code itself. During this month’s interview we spoke about Chronomics’ development and their realization in of the potential of epigenetic testing for personal health. I discussed with Tom the key challenges Chronomics overcame in their growth as an early-stage biotech company and his advice to aspiring entrepreneurs in the life sciences.
The idea was initially developed by its CEO Timothy Brownstone, who had previously read a NASA research paper whilst at university discussing how infrared could be used to aid the growth of plants in space. With the understanding of this infrared technology, Tim set out to develop the concept of KYMIRA Sport which embeds Far Infrared (FIR) producing technology into the fabric of its sports clothing products. The technology in the fabric enhances the user’s performance and recovery during intense training and exercise by absorbing the waste energy from the body and latent energy from the environment. This energy is converted into FIR which increases the production of nitric oxide which then leads to increases in circulation, tissue oxygenation, energy production, pain relief and an increased efficiency in respiration.
Looking for affordable office and lab space in London? - Join Open Cell
Join an exciting pool of talented scientists, designers and early-stage businesses in Shepherd's Bush Open Cell bio-space. Open Cell contains 20 containers for early-stage startups, 10 studio spaces and 10 fully equipped labs. The Open Cell aims to provide affordable lab and office space to create and foster an innovation-driven environment for the next generation of scientist-entrepreneurs.
The human body contains trillions of micro-organisms, with an estimated 3.8∙10^13 bacterial cells accounting for up to 0.2 kg of body weight (Sender, R. et al., 2016). These microbes live within us in a symbiotic relationship and research has led to the understanding that they prove vital to our physiological functions. As vital as they are in remaining healthy, they are highly associated with causing or contributing to the development of many chronic diseases. These microbes are collectively known as ‘the human microbiota’ and the ‘microbiome’ is the term which describes the genes of all these microbes. The microbiome is unique to every individual and the extent to which it affects vital bodily functions is only just beginning to be really understood.
London, United Kingdom -- Clustermarket, the online sharing platform helping scientists, engineers and other technology pioneers to get easy and affordable access to equipment and services just announced a strategic partnership with RebelBio, the world's first early-stage life sciences accelerator with programmes in London and Cork. Clustermarket is providing companies backed by RebelBio access to the resources they need on demand with exclusive offers.
How many times you went around your department looking for a specific piece of equipment to use for just that one experiment? How many times you asked around your colleagues if they knew someone that had expertise on the new experiment you were trying to set up?
After the boom of “sharing economy”, in which people rent beds, cars, boats and other assets directly from each other, coordinated via the internet, for the first time we are able to book expertise, lab space and lab equipment outside our institution via an online platform: Clustermarket.
For the first time , companies and scientists will be able to book expertise, lab space and equipment outside their institution via an online platform, creating a new dawn for independent life science research in the UK.
Clustermarket (www.clustermarket.com) has launched in partnership with Merck Accelerator as the UK’s first online marketplace for scientists – enabling grassroots scientific research and ‘access for all’ in life sciences.
A new online sharing platform for life science research just launched has attracted hundreds of life science entrepreneurs and has bridged the gap toward making the UK more competitive in terms of commercialisation of scientific research.
Clustermarket CEO Johannes Solzbach says while the UK makes claims to being a global leader in science and research, the country has failed to compete when it comes to commercialisation and his platform, www.clustermarket.com, has set out to bridge this.